Analog company starts with technology

It can be said that Jiro Asada had already thought of all subsequent countermeasures when he decided to let anti-cancer drugs enter the market early.

So even if Iku Nakamura came to him about this matter, he wasn't worried at all.

And it's worth mentioning.

Jiro Asada moved very quickly, almost leaving Iku Nakamura, and he immediately arranged a press conference.

It is planned to hold a press conference to explain the fact that anti-cancer drugs do not show efficacy when used by many patients.

Although it would be unconvincing for many patients' families to attribute this problem entirely to the different physical constitutions of patients, no matter how large the number of cancer patients in China is, looking at the whole country, they are only a small number of people.

In Jiro Asada's view, as long as the families of these patients can be comforted and given some appropriate compensation.

This storm will be over soon.

At least it won't threaten his own status.

It is impossible for a society that has just restored stability to fall back into chaos because of this incident.

As for Bay Island, which also uses this anti-cancer drug, it is not within the scope of Asada Jiro's consideration.

that's all.

As soon as December entered, Jiro Asada's press conference was held in Tokyo as scheduled.

In order to increase the persuasiveness of the press conference, in addition to inviting reporters from the news media, some cancer patients and their families were also specially invited.

It can be said that we are fully prepared.

certainly.

These patients and their families have reached private settlement agreements.

So the entire press conference went very smoothly.

Although the public's trust in the new anti-cancer drug dropped significantly in the end, thinking that it was no different from ordinary anti-cancer drugs on the market, at least it was not devalued as worthless, which was basically within Jiro Asada's expectations.

Anyway, as long as there are no big problems, everything will be fine.

The whole thing only used a little compensation for the patients to restore society to a stable state, and even the economy was on the road to recovery.

No matter how you look at it.

Jiro Asada thought he had made a profit.

Even his position in the cabinet will be much more stable.

While the island side was still holding a press conference to resolve public doubts, Jingzhou City was completely on track, and a large number of Momofuku injections began to be produced by Xingyuan Biotech.

And the first batch is expected to be launched at the end of the month.

Monday, December 4th.

Imperial capital.

Medical Bureau.

Qin Xiaoman, the person in charge of Xingyuan Biology, suddenly appeared in the director's office.

"Vice President Qin, on behalf of the millions of cancer patients across the country, I would like to thank your company for its great contribution." Hu Hai, who was full of excitement, held a document in both hands and expressed his inner feelings sincerely.

Qin Xiaoman saw this scene in his eyes, with a generous smile on his lips, and replied: "Director Hu is serious, this matter is a decision made by our boss Niu, and it is also what Xingyuan Technology should do as a top domestic technology company. Things to do."

"Anyway, thank you."

"With this, so many cancer patients in the country can be saved."

Hu Hai never took his eyes away from the document in his hand, and his words were full of happiness and joy.

Because this is Xingyuan Biotechnology’s decision to include Pfaff Injection in the scope of medical insurance, the weight of it can be imagined.

If it were an ordinary drug, perhaps Hu Hai wouldn't be too excited, but when faced with the Pfaff injection that went viral recently on the Internet, he couldn't control himself at all.

After the clinical trial data of Pfaff injection were released, the whole country was shocked.

In addition to arousing heated discussions among everyone, the above naturally also attracted great attention.

I had the idea of ​​contacting star-source creatures.

After all, it is the first universal anti-cancer drug in China, and its effectiveness surpasses that of various well-known overseas anti-cancer drugs. It is definitely great news for cancer patients.

But the research and development costs of anti-cancer drugs are there, and the prices of anti-cancer drugs imported from outside are so expensive. If Xingyuan Biotech prices Pfaff injection too high, it may be difficult for domestic cancer patients to accept it.

It is easy to cause various social conflicts.

Therefore, they plan to provide certain subsidies to Xingyuan Biotech in the official name to reduce the price of Pfaff injection.

This allows cancer patients to use it stress-free.

But I never expected that the person in charge of Xingyuan Biology would come to the door today before this matter was officially implemented.

You should also take the initiative to join medical insurance.

It just takes no effort at all.

However, not all medicines can be covered by medical insurance. If the price quoted for Baifu injection is too high, the state cannot cover it all. After all, the expenditure is too great.

Thinking of this, Hu Hai's mood gradually calmed down.

After temporarily putting down the documents, he asked Qin Xiaoman: "Vice President Qin, I wonder what your company's quotation for Baifu injection is?"

In fact, medical insurance negotiations are not about asking pharmaceutical companies to lower prices as much as possible, but they need to be within a reasonable range.

Hu Hai naturally has a price point for the Pfaff injection produced by Xingyuan Biotechnology. As long as it is not too high, he will agree to Xingyuan Biotechnology's application and conduct centralized procurement of Pfaff injection.

Who makes this matter to the physical condition of millions of cancer patients.

It’s worth spending the extra money.

Qin Xiaoman rushed to the imperial capital from Jingzhou City. He must have been ordered by Niu Geng. The quotation for Baifu injection was also discussed before coming.

In this case, Qin Xiaoman did not intend to waste time.

After all, it is an important time for the production of the first batch of Pfaff injections, so more attention is needed.

She will return immediately after settling the matter here.

So after clearing his throat, he slowly stretched out two fingers: "According to Mr. Niu's instructions, the price of each Baifu injection is two thousand yuan."

Two...two thousand yuan?

"Vice President Qin, are you sure you're right?"

When Hu Hai heard this number, he was stunned for a moment, and then only two large and clear characters were left on his face.

Shock!

Yes, it was a shock.

The price of two thousand yuan per tube may be relatively high among other types of drugs, but as an anti-cancer drug, it is actually not high.

It was even far lower than the price Hu Hai had in mind.

To be honest, after Hu Hai has dealt with so many pharmaceutical companies, this is the first time he has encountered a company that does not care about his own interests. He is a role model among role models.

I'm afraid no other company can do it.

More importantly, Pfaff injection is different from other anti-cancer drugs that need to be taken for a long time.

Even patients with advanced cancer only need three injections.

According to the price quoted now, it is only 6,000 yuan in full.

Basically every cancer patient can afford it.

In this way, there should be no talk of cancer in the country in the future, and it’s not like we can’t afford medicine anyway.

Qin Xiaoman, who saw this scene in her eyes, had a look of pride in her eyes at this moment, because the decision she heard from Niu Geng before she came to the imperial capital was also very unexpected.

Although setting a price of 2,000 per stick will not make the company lose money, it will only make a profit at most, but there are very few people who are willing to do this.

So Qin Xiaoman quickly replied: "Director Hu, you heard it right."

"Our President Niu said that the development of Xingyuan Technology to its current scale is indispensable with the help from above and everyone's support. Now that the company is lucky enough to develop Pfaff Injection, it must benefit society."

"I wonder if Director Hu is satisfied with this quotation?"

When these words reached his ears, Hu Hai finally confirmed the facts.

Although it was still hard to accept, he immediately nodded and said: "Of course I am satisfied."

The reason why Niu Geng chose to cooperate with the Medical Insurance Bureau was after careful consideration and not a decision made rashly.

Major cancer patients are located all over the country, and most of them live in small counties or rural areas like the uncle before. It is difficult for these people to use Pfaff injections solely relying on the power of the company.

In addition, we still need to solve the sales situation and establish contact with the hospital. It is better to package it directly and let the higher-ups purchase it.

Besides, earning less profit is nothing to Niu Geng.

Xingyuan Technology is now at its peak, with huge amounts of money coming in every day. There is no need to make money for medicine.

What's more, the company will still be responsible for the sales of Pfaff injections overseas, and the pricing will definitely be different from that in China.

It was based on these considerations that Niu Geng made this decision.

Let Qin Xiaoman make a trip.

——

The matter has almost come to an end at this point. All that needs to be done is to sign a purchase agreement. After all, both parties have reached a consensus, and there is no need for several rounds of negotiations like other pharmaceutical companies.

Considering that there are still many things waiting for him to deal with in the company, Qin Xiaoman does not want to waste too much time.

Then he stood up and walked to Hu Hai, and took the initiative to say: "Director Hu, the first batch of Baifu injections should be delivered at the end of the month. I hope you can allocate them reasonably."

"Don't worry, we will give priority to terminally ill patients with the first batch of injections."

Hu Hai also stood up and shook hands with Qin Xiaoman in a formal way, and promised again and again.

Because the number of the first batch of Pfaff injections is definitely limited, but they are facing millions of cancer patients in the country, and there is definitely no way to satisfy them all.

In this case, it is the most appropriate way to prioritize the supply to patients with advanced cancer from above.

Niu Geng also thought about this problem, and then added the idea of ​​​​cooperating with the Medical Insurance Bureau.

More importantly, this approach can also avoid controversy online.

Otherwise, if Xingyuan Biotech really handles this matter, once cancer patients and their families fail to purchase Pfaff injection, it will inevitably cause huge public opinion on the Internet.

It is not conducive to the sustainable development of the company.

"I am very reassured by Director Hu's words, so I will take my leave first."

As Qin Xiaoman said something again, he prepared to leave, but just as he turned around and stepped out, Hu Hai's voice came from behind again.

"Wait a minute, Vice President Qin, I have something else that I may need your help with."

"Oh, Director Hu, just say it."

Hearing the sound, Qin Xiaoman stopped and turned around again, asking.

Hu Hai: "That's it, Vice President Qin. We happen to be negotiating with several pharmaceutical companies today. If we don't come back, can you delay a little time to participate?"

After listening to Hu Hai's words, Qin Xiaoman quickly thought of what he meant as his mind wandered a little.

Negotiating with pharmaceutical companies is different from buying vegetables at the wet market, which generally lasts a very long time.

And it is torture for both parties.

Hu Hai asked Qin Xiaoman to participate in this negotiation, naturally to take the lead. This might allow those pharmaceutical companies to quote their lowest price from the beginning, which is equivalent to saving time for everyone.

Qin Xiaoman figured this out and knew that he only needed to go through the motions, so there was no reason to refuse.

He responded without much hesitation: "No problem, it would be great if I can help Director Hu."

"Vice President Qin, please come this way."

Seeing Qin Xiaoman agreeing to his request, Hu Hai suddenly felt a move in his heart and immediately led Qin Xiaoman towards the conference room in person.

…

at the same time.

In the large conference room of the Medical Bureau, representatives from several pharmaceutical companies from across the country were sitting here, waiting for the negotiations to officially begin.

Although he looks very calm on the outside, judging from the small movements of his body, he is still quite nervous inside.

After all, they are all representatives sent by the pharmaceutical company. They must not lose the election when participating in this negotiation, but they must also strive for the best interests of the company as much as possible, otherwise life will not be so easy after they return.

But at this moment, they noticed that the staff had placed a new name on the empty seat next to them, and they couldn't help but whisper.

"Qin Xiaoman, why haven't you heard of this person?"

"Hasn't the person who will be participating in the negotiation today been decided a long time ago? Why is there suddenly one more person?"

"I stopped in the middle, could it be a related party who used the back door?"

"It seems that it is impossible to be selected with a higher offer this time. The competition seems to be much greater than last year."

"Do you need to report this situation to the company? I feel that it is not that simple to add this person suddenly. I must prepare in advance."

"Does anyone know this guy?"

"I found out that this Qin Xiaoman seems to be the vice president of Xingyuan Biotechnology, responsible for the operation of the company's various businesses, but why is she here?"

…

The sudden appearance of new people made other representatives of the surrounding pharmaceutical companies feel even more nervous.

They have even begun soliciting lower offers from above.

But after learning that Qin Xiaoman was the person in charge of Xingyuan Creatures, a big question mark emerged in their minds?

They couldn’t figure out why Xingyuan Biotech would participate in medical insurance drug negotiations.

Although Xingyuan Biotech is an emerging company, the launch of Baifu Injection is a huge earthquake for the entire medical industry. How could they not know about it.

It’s just that in their opinion, Xingyuan Biotech has such a powerful anti-cancer drug, so it should take advantage of the opportunity to quickly earn back the funds invested in early research. Not to mention the ridiculously high price, at least it must import anti-cancer drugs from foreign countries. The price is about the same.

Moreover, there is such a huge demand for medicines in China alone that there is no need to go through centralized procurement.

Unless the boss of Xingyuan Biology is crazy, he will come here.

Unfortunately, just as they were preparing to learn more about the situation, Qin Xiaoman and Hu Hai walked in together, which also marked the official start of the pharmaceutical company negotiations.

If you have any questions, you can only take one step at a time.